Seltenere Tumoren und Tumortypen des ableitenden Harnsystems in der 5. Aufl. der WHO-Klassifikation 2022
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acosta AM, Sholl LM, Fanelli GN et al (2021) Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants. Mod Pathol 34:457–468
Alexiev BA, Tavora F (2013) Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems. Virchows Arch 462:193–201
Almassi N, Whiting K, Toubaji A et al (2022) Clinical and genomic characterization of bladder carcinomas with glandular phenotype. JCO Precis Oncol 6:e2100392
Amin MB, Smith SC, Eble JN et al (2014) Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification. Am J Surg Pathol 38:1033–1045
Urinary bladder (2017) Urinary bladder. In: Brierly JD, Gospodarowicz MK, Wittekind C (Hrsg) TNM classification of malignant tumours. Wiley-VCH, Weinheim, S S 259–S 261
WHO Classification of Tumours of the Urinary System and the Male Genital Organs (2016) 4. Aufl. International Agency for Research on Cancer (IARC), Lyon
Ashley RA, Inman BA, Sebo TJ et al (2006) Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer 107:712–720
Comperat EM, Netto GJ, Tsuzuki T (2022) Tumours of the urinary tract. In: WHO classification of tumours of the urinary system and the male genital organs, 5. Aufl. International Agency for Research on Cancer (IARC), Lyon, S 132–191
Corica FA, Husmann DA, Churchill BM et al (1997) Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up. Urology 50:427–431
Deuker M, Stolzenbach LF, Colla Ruvolo C et al (2021) Upper urinary tract tumors: variant histology versus urothelial carcinoma. Clin Genitourin Cancer 19:117–124
Donnez J, Spada F, Squifflet J et al (2000) Bladder endometriosis must be considered as bladder adenomyosis. Fertil Steril 74:1175–1181
Gaisa NT, Hartmann A, Knuchel-Clarke R (2023) New WHO classification 2022: urinary bladder cancer. Pathologie 44:139–148
Gordetsky J, Epstein JI (2015) Intestinal metaplasia of the bladder with dysplasia: a risk factor for carcinoma? Histopathology 67:325–330
Grignon DJ, Ro JY, Ayala AG et al (1991) Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases. Cancer 67:2165–2172
Hager T, Kraywinkel K, Szarvas T et al (2020) Urachal Cancer in Germany and the USA: an RKI/SEER population-based comparison study. Urol Int 104:803–809
Herawi M, Drew PA, Pan CC et al (2010) Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma. Hum Pathol 41:594–601
Hisamatsu H, Sakai H, Igawa T et al (2003) Adenoid cystic carcinoma of Cowper’s gland. BJU Int 92(Suppl 3):e56–e57
Jones D, Guan JJ, Calagua C et al (2019) Primary adenocarcinoma of the bladder lacks mismatch repair deficiency and demonstrates PD-L1 expression in tumor-infiltrating immune cells, with implications in both diagnosis and therapeutics. Hum Pathol 94:58–63
Kamoun A, De Reynies A, Allory Y et al (2020) A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77:420–433
Koll FJ, Banek S, Kluth L et al (2023) Tumor-associated macrophages and tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis. J Transl Med 21:124
Lim M, Adsay NV, Grignon D et al (2009) Urothelial carcinoma with villoglandular differentiation: a study of 14 cases. Mod Pathol 22:1280–1286
Limonnik V, Samiei A, Abel S et al (2023) Urachal carcinoma: a novel staging system utilizing the National Cancer Database. Cancer Med 12:2752–2760
Lin CY, Saleem A, Stehr H et al (2019) Molecular profiling of clear cell adenocarcinoma of the urinary tract. Virchows Arch 475:727–734
Maurer A, Ortiz-Bruechle N, Guricova K et al (2020) Comparative genomic profiling of glandular bladder tumours. Virchows Arch 477:445–454
Myers CE, Gatalica Z, Spinelli A et al (2014) Metastatic cancer of cowper’s gland: a rare cancer managed successfully by molecular profiling. Case Rep Oncol 7:52–57
Nagy N, Reis H, Hadaschik B et al (2020) Prevalence of APC and PTEN alterations in urachal cancer. Pathol Oncol Res 26:2773–2781
Necchi A, Madison R, Raggi D et al (2020) Comprehensive assessment of immuno-oncology biomarkers in adenocarcinoma, urothelial carcinoma, and squamous-cell carcinoma of the bladder. Eur Urol 77:548–556
Ortiz-Bruchle N, Wucherpfennig S, Rose M et al (2021) Molecular characterization of muellerian tumors of the urinary tract. Genes 12:880
Paner GP, Annaiah C, Gulmann C et al (2014) Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol 45:1473–1482
Paner GP, Barkan GA, Mehta V et al (2012) Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol 36:432–442
Paner GP, Kamat A, Netto GJ et al (2024) International Society of Urological Pathology (ISUP) consensus conference on current issues in bladder cancer. Working group 2: grading of mixed grade, invasive urothelial carcinoma including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. Am J Surg Pathol 48:e11–e23
Pinthus JH, Haddad R, Trachtenberg J et al (2006) Population based survival data on urachal tumors. J Urol 175:2042–2047
Raspollini MR, Carini M, Montironi R et al (2015) Mucinous adenocarcinoma of the male urethra: a report of two cases. Anal Quant Cytopathol Histpathol 37:267–272
Reis H, Krafft U, Niedworok C et al (2018) Biomarkers in urachal cancer and adenocarcinomas in the bladder: a comprehensive review supplemented by own data. Dis Markers 2018:7308168
Reis H, Szarvas T (2018) Urachal cancer—current concepts of a rare cancer (German version). Pathologe 39:291–300
Royce TJ, Lin CC, Gray PJ et al (2018) Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: results from the National Cancer Data Base. Urol Oncol 36:78 e71–78 e12
Sethi S, Dhawan S, Chopra P (2011) Clear cell adenocarcinoma of urinary bladder: a case report and review. Urol Ann 3:151–154
Soave A, Schmidt S, Dahlem R et al (2015) Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol 33:21 e21–21 e29
Tregnago AC, Epstein JI (2018) Skene’s glands adenocarcinoma: a series of 4 cases. Am J Surg Pathol 42:1513–1521
Ueda Y, Mandai M, Matsumura N et al (2012) Adenoid cystic carcinoma of skene glands: a rare origin in the female genital tract and the characteristic clinical course. Int J Gynecol Pathol 31:596–600
Varadi M, Nagy N, Reis H et al (2023) Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas. Cancer Med 12:9041–9054
Wasco MJ, Daignault S, Zhang Y et al (2007) Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology 70:69–74
Wucherpfennig S, Rose M, Maurer A et al (2021) Evaluation of therapeutic targets in histological subtypes of bladder cancer. Int J Mol Sci 22:11547
Young RH, Scully RE (1985) Clear cell adenocarcinoma of the bladder and urethra. A report of three cases and review of the literature. Am J Surg Pathol 9:816–826
Zaghloul MS, Nouh A, Nazmy M et al (2006) Long-term results of primary adenocarcinoma of the urinary bladder: a report on 192 patients. Urol Oncol 24:13–20
Zhang M, Pettaway C, Vikram R et al (2016) Adenoid cystic carcinoma of the urethra/Cowper’s gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol 58:138–144